Clinical Trial

Investigation of the Impact of Myomectomy on Uterine Artery Doppler Velocimetry Findings

Study acronym: MYO-DOP
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 15, 2026 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
Objective: This scientific study aims to investigate whether myomectomy induces significant changes in uterine artery blood flow patterns. While Doppler ultrasonography is traditionally used to assess myoma vascularity, differential diagnosis (adenomyoma or sarcoma), and fertility impacts, there is a lack of prospective evidence comparing preoperative and postoperative uterine artery Doppler findings. Study Design and Rationale: The study will evaluate the hemodynamic influence of myomectomy by comparing flow measurements in the main uterine artery before and after surgical intervention. Existing literature has primarily focused on the correlation between myoma volume and vascular resistance; however, the direct impact of surgical removal of a myoma on uterine artery doppler velocimetry remains under-investigated. Participant Involvement: Participation is entirely voluntary, and participants may withdraw at any time without any impact on their medical care. Data collection involves routine clinical history, physical examination, and non-invasive ultrasound measurements. Clinical Significance: By establishing the effect of myoma removal on uterine blood supply, this research aims to provide guiding data for the follow-up and treatment planning of patients with leiomyomas. The findings may offer new insights into how surgical management restores or alters uterine hemodynamics, potentially influencing future diagnostic and therapeutic approaches.
Trial Details
NCT Number NCT07343765
Lead Sponsor Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Conditions Leiomyoma (Uterine Fibroids), Myomectomy, Doppler Ultrasound
Enrollment 70 participants
Start Date 2025-09-01
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-15